DCM
RMD icon

Decatur Capital Management’s ResMed RMD Stock Holding History

Decatur Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,656
Closed -$1.61M – 62
2022
Q1 		$1.61M Buy
6,656
+664
+11% +$161K 0.94% 38
2021
Q4 		$1.56M Sell
5,992
-60
-1% -$15.6K 0.92% 37
2021
Q3 		$1.59M Sell
6,052
-7,126
-54% -$1.95M 1.05% 28
2021
Q2 		$3.25M Sell
13,178
-6,725
-34% -$1.41M 1.02% 32
2021
Q1 		$3.86M Sell
19,903
-17,900
-47% -$3.59M 1.33% 22
2020
Q4 		$8.04M Buy
+37,803
New +$7.54M 1.47% 17

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Decatur Capital Management's RMD Position: Q2 2022 in Review

Decatur Capital Management sold out of ResMed (RMD) in Q2 2022, closing a stake of 6,656 shares — an estimated $1.61M sold.

Decatur Capital Management first reported a position in RMD in Q4 2020 and held it in 6 quarters. The position peaked at $8.04M in Q4 2020. 676 funds tracked by Wall St. Rank hold RMD as of Q2 2022.

  • Decatur Capital Management reported no remaining ResMed position as of Q2 2022 after selling out during the quarter.
  • Decatur Capital Management sold 6,656 ResMed shares in Q2 2022, an estimated $1.61M.
  • Decatur Capital Management first reported a position in ResMed in Q4 2020 and held it in 6 quarters.
  • Decatur Capital Management's ResMed position peaked at $8.04M in Q4 2020.
  • 676 funds tracked by Wall St. Rank held ResMed as of Q2 2022.

Based on Decatur Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.